| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/24/2009 | WO2009116880A2 Process for obtaining powder compositions of orlistat |
| 09/24/2009 | WO2009116764A2 Cell migration, cell infiltration, or neovascularization inhibitor through degradation of function of ptk7 protein |
| 09/24/2009 | WO2009116556A1 Pharmaceutical composition for injection |
| 09/24/2009 | WO2009116382A1 Inhibitor for blood phosphorus level elevation |
| 09/24/2009 | WO2009116257A1 Therapeutic agent for fibroid lung |
| 09/24/2009 | WO2009116078A2 Oral dosage formulations and process of preparation thereof |
| 09/24/2009 | WO2009116077A2 Injectable preparations and a process of preparation thereof |
| 09/24/2009 | WO2009116076A2 Sterile opthalmic preparations and a process for preparation thereof |
| 09/24/2009 | WO2009116047A2 Solid dosage form for treating headaches |
| 09/24/2009 | WO2009115967A2 Method for the synthesis of hollow spheres |
| 09/24/2009 | WO2009115579A1 Biodegradable nanoshells for delivery of therapeutic and/or imaging molecules |
| 09/24/2009 | WO2009115525A2 Preparation of a pharmaceutical composition for increasing bone mineral density |
| 09/24/2009 | WO2009115510A1 Antiviral formulation |
| 09/24/2009 | WO2009115301A1 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
| 09/24/2009 | WO2009115280A1 Remineralizing saliva substitute and method for the production thereof |
| 09/24/2009 | WO2009115272A1 Remineralizing dental care product and method for the production thereof |
| 09/24/2009 | WO2009115235A1 Pde inhibitors for the treatment of pulmonary hypertension |
| 09/24/2009 | WO2009115178A2 Gingival wafer |
| 09/24/2009 | WO2009115175A2 Lyophilized nanoemulsion |
| 09/24/2009 | WO2009115160A2 Chewing composition and the use thereof |
| 09/24/2009 | WO2009115053A1 Injectable sustained-release pharmaceutical formulation and the preparation method thereof |
| 09/24/2009 | WO2009115023A1 A anthocyanins phospholipid complex and the preparative method thereof |
| 09/24/2009 | WO2009114959A1 Injectalble sustained-release pharmaceutical formulation and method for preparing it |
| 09/24/2009 | WO2009084040A4 Once a day formulation of angiotensin receptor blockers |
| 09/24/2009 | WO2009074662A3 Organic compounds |
| 09/24/2009 | WO2009067221A3 Microemulsion containing indolocarbazole compound and dosage forms containing the same |
| 09/24/2009 | WO2009066315A3 Sustained release compositions of trimetazidine and process for preparation thereof |
| 09/24/2009 | WO2009055568A3 Liposomal vancomycin formulations |
| 09/24/2009 | WO2009052256A3 Bowel purgative and uses thereof |
| 09/24/2009 | WO2009051648A3 Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same |
| 09/24/2009 | WO2009048532A3 Formation of particles for ultrasound application, drug release, and other uses, and microfluidic methods of preparation |
| 09/24/2009 | WO2009047802A3 Novel colon targeted modified release bioadhesive formulation of 5-amino salicylic acid or its salts and metabolites thereof |
| 09/24/2009 | WO2009047006A3 Amphoteric liposomes comprising neutral lipids |
| 09/24/2009 | WO2009044406A3 Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof |
| 09/24/2009 | WO2009026427A3 Liposome compositions for in vivo administration of boronic acid compounds |
| 09/24/2009 | WO2009019307A3 Oral calcitonin compositions and applications thereof |
| 09/24/2009 | WO2008143992A3 Improved depot formulations |
| 09/24/2009 | WO2008140772A3 Robust rapid disintegration tablet formulation |
| 09/24/2009 | WO2008129468A9 Pharmaceutical compositions of clopidogrel |
| 09/24/2009 | WO2008116601A4 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof |
| 09/24/2009 | WO2007149438A3 Pharmaceutical compositions |
| 09/24/2009 | WO2007080308A3 Thermoreversible oil-in-water emulsion |
| 09/24/2009 | US20090240337 Methods, Devices and Compositions for Adhering Hydrated Polymer Implants to Bone |
| 09/24/2009 | US20090240240 Disposable infusion device with actuation lock-out |
| 09/24/2009 | US20090239842 Solutions containing epinastin |
| 09/24/2009 | US20090238907 Topical Compositions Containing Bacillus Coagulans Extracellular Products and Uses Thereof |
| 09/24/2009 | US20090238890 Continuous spray-capture production system |
| 09/24/2009 | US20090238888 Radical polymerization method and products prepared thereby |
| 09/24/2009 | US20090238887 Highly Impact-Resistant Granules |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238885 Protein encapsulated particles |
| 09/24/2009 | US20090238884 Compositions for site-specific delivery of imatinib and methods of use |
| 09/24/2009 | US20090238883 Liver-specific nanocapsules and methods of using |
| 09/24/2009 | US20090238882 Carbon-substituted diketopiperazine delivery systems |
| 09/24/2009 | US20090238881 Ionophore antibiotic formulations |
| 09/24/2009 | US20090238880 Phospholipid-based pharmaceutical formulations and methods for producing and using same |
| 09/24/2009 | US20090238879 Delivery scaffolds and related methods of use |
| 09/24/2009 | US20090238878 Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances With Reduced Ostwald Ripening |
| 09/24/2009 | US20090238877 Agent For Improving Fine Wrinkles |
| 09/24/2009 | US20090238876 Bisphosphonates for treating endometriosis |
| 09/24/2009 | US20090238875 Chitosan or Hyaluronic Acid-Poly(Ethylene Oxide)-and Chitosan-Hyaluronic Acid-Poly(Ethylene Oxide)-Based Hydrogel and Manufacturing Method Therefor |
| 09/24/2009 | US20090238874 Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan |
| 09/24/2009 | US20090238873 Extended release formulation containing a wax |
| 09/24/2009 | US20090238872 Chlorine dioxide releasing composite article |
| 09/24/2009 | US20090238871 Pharmaceutical composition |
| 09/24/2009 | US20090238870 Dividable galenical form allowing modified release of the active ingredient |
| 09/24/2009 | US20090238869 Propranolol formulations |
| 09/24/2009 | US20090238868 Abuse-resistant oral dosage forms and method of use thereof |
| 09/24/2009 | US20090238867 Nanoparticulate Anidulafungin Compositions and Methods for Making the Same |
| 09/24/2009 | US20090238866 Chewable capsules |
| 09/24/2009 | US20090238865 Lipid nanocapsules, preparation process and use as medicine |
| 09/24/2009 | US20090238864 Dna vaccines encoding heat shock proteins |
| 09/24/2009 | US20090238863 Liposome composition for induction of immunity |
| 09/24/2009 | US20090238862 Methods and Compositions for Seprase Inactivation |
| 09/24/2009 | US20090238861 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
| 09/24/2009 | US20090238860 Adhesive Patch Less Irritative to Skin |
| 09/24/2009 | US20090238859 Sinus delivery of sustained release therapeutics |
| 09/24/2009 | US20090238858 Compositions and Methods for Treating Ophthalmic Diseases |
| 09/24/2009 | US20090238849 Stretchable laminated sheet |
| 09/24/2009 | US20090238846 S/O type external preparation |
| 09/24/2009 | US20090238774 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
| 09/24/2009 | US20090238772 Methods and compositions for prevention or treatment of rsv infection |
| 09/24/2009 | US20090238771 Pharmaceutical formulations |
| 09/24/2009 | US20090238770 Organic compounds |
| 09/24/2009 | US20090238758 Random and non-random alkylene oxide polymer alloy compositions |
| 09/24/2009 | DE102008015961A1 Verwendung von Gelatinepartikeln in Pulverbeschichtungsverfahren Use of gelatin particles in powder coating process |
| 09/24/2009 | DE102008015366A1 Lyophilisierte Nanoemulsion Lyophilized nanoemulsion |
| 09/24/2009 | DE102008015299A1 Kolloidales Trägersystem Colloidal carrier system |
| 09/24/2009 | DE102008015101A1 Kauzusammensetzung und deren Verwendung Kauzusammensetzung and their use |
| 09/24/2009 | CA2755492A1 Solid dosage form for treating headaches |
| 09/24/2009 | CA2718966A1 Anti-inflammatory drug delivery system |
| 09/24/2009 | CA2718915A1 Pharmaceutical composition and a method for the production thereof |
| 09/24/2009 | CA2718866A1 Ophthalmic solutions displaying improved efficacy |
| 09/24/2009 | CA2718864A1 Phosphate buffered ophthalmic solutions displaying improved efficacy |
| 09/24/2009 | CA2718791A1 Lyophilized nanoemulsion |
| 09/24/2009 | CA2718715A1 Nerve repair with a hydrogel and optional adhesive |
| 09/24/2009 | CA2718697A1 Extended release formulation containing a wax |
| 09/24/2009 | CA2718560A1 Therapeutic agent for fibroid lung |
| 09/24/2009 | CA2718231A1 Emulsions including a peg-derivative of tocopherol |
| 09/24/2009 | CA2718065A1 Gingival wafer |